Literature DB >> 20438026

Corneal infiltrates after corneal collagen cross-linking.

George F Mangioris1, Domniki N Papadopoulou, Miltiadis O Balidis, Jordan L Poulas, Nikolaos Th Papadopoulos, Theo Seiler.   

Abstract

PURPOSE: To present a case of advancing keratoconus treated with corneal collagen cross-linking (CXL) with ultraviolet A (UVA) light and riboflavin complicated with sterile infiltrates.
METHODS: The patient's cornea was de-epithelialized and CXL was performed with application of riboflavin and exposure to UVA light (370 nm, 3 mW/cm2) for 30 minutes.
RESULTS: Early in the postoperative period, the patient presented with 11 deep stromal infiltrates of 1 to 2 mm with clear demarked edges in a circle near the limbus with some clear cornea. Corneal cultures were negative. Treatment consisted of antibiotic ofloxacin and tobramycin four times daily, and dexamethasone drops six times daily. After 2 months, scars remained evident.
CONCLUSIONS: This complication has not been reported previously and may be an individual hypersensitivity reaction to the riboflavin or UVA light in the anterior stroma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20438026     DOI: 10.3928/1081597X-20100326-01

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  11 in total

Review 1.  [Complications of corneal cross-linking].

Authors:  T G Seiler; G Schmidinger; I Fischinger; T Koller; T Seiler
Journal:  Ophthalmologe       Date:  2013-07       Impact factor: 1.059

Review 2.  Corneal collagen cross-linking using riboflavin and ultraviolet-A irradiation: a review of clinical and experimental studies.

Authors:  Maria Gkika; Georgios Labiris; Vassilios Kozobolis
Journal:  Int Ophthalmol       Date:  2011-08-17       Impact factor: 2.031

Review 3.  Safety and efficacy of epithelium removal and transepithelial corneal collagen crosslinking for keratoconus.

Authors:  Z Shalchi; X Wang; M A Nanavaty
Journal:  Eye (Lond)       Date:  2014-10-03       Impact factor: 3.775

4.  Collagen cross-linking using riboflavin and ultraviolet-a for corneal thinning disorders: an evidence-based analysis.

Authors:  G Pron; L Ieraci; K Kaulback
Journal:  Ont Health Technol Assess Ser       Date:  2011-11-01

5.  Sterile keratitis after combined riboflavin-UVA corneal collagen cross-linking for keratoconus.

Authors:  F C Lam; P Georgoudis; P Geourgoudis; M A Nanavaty; S Khan; D Lake
Journal:  Eye (Lond)       Date:  2014-08-08       Impact factor: 3.775

6.  Higher incidence of steroid-induced ocular hypertension in keratoconus.

Authors:  Anastasios John Kanellopoulos; Emerson M Cruz; Robert Edward T Ang; George Asimellis
Journal:  Eye Vis (Lond)       Date:  2016-02-23

7.  Conventional and transepithelial corneal cross-linking for patients with keratoconus.

Authors:  Xiaoyu Zhang; Jing Zhao; Meiyan Li; Mi Tian; Yang Shen; Xingtao Zhou
Journal:  PLoS One       Date:  2018-04-05       Impact factor: 3.240

Review 8.  Updates on Managements for Keratoconus.

Authors:  Mehrdad Mohammadpour; Zahra Heidari; Hassan Hashemi
Journal:  J Curr Ophthalmol       Date:  2017-12-06

9.  Epi-Bowman keratectomy versus alcohol-assisted photorefractive keratectomy: wound healing and complications.

Authors:  Suphi Taneri; Saskia Kießler; Anika Rost; Tim Schultz; H Burkhard Dick
Journal:  Ther Adv Ophthalmol       Date:  2021-01-22

Review 10.  Updates on corneal collagen cross-linking: Indications, techniques and clinical outcomes.

Authors:  Mehrdad Mohammadpour; Ahmad Masoumi; Masoud Mirghorbani; Kianoosh Shahraki; Hassan Hashemi
Journal:  J Curr Ophthalmol       Date:  2017-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.